Related Experiment Video

Updated: Jun 18, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Protein tyrosine phosphatases in glioma biology

Anna C Navis1, Monique van den Eijnden, Jan T G Schepens

  • 1Department of Cell Biology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, 6525 GA Nijmegen, The Netherlands.

Acta Neuropathologica
|November 26, 2009
PubMed

Insights

Protein tyrosine phosphatases (PTPs) are implicated in glioma development, offering new therapeutic targets. Research highlights their role in brain tumors, suggesting novel diagnostic and treatment strategies for gliomas.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gliomas are aggressive brain tumors with poor prognosis due to diffuse infiltration and chemotherapy resistance.
  • Recent advances in molecular biology have identified key signaling pathways in glioma pathogenesis.
  • Protein tyrosine phosphatases (PTPs) are crucial regulators of cell signaling, yet their role in gliomas remains understudied compared to protein tyrosine kinases (PTKs).

Purpose of the Study:

  • To provide a comprehensive overview of the current knowledge regarding the involvement of PTPs in glioma biology and tumorigenesis.
  • To explore the potential of PTPs as therapeutic targets for high-grade gliomas.

Main Methods:

  • Literature review and synthesis of existing research on PTPs in glioma.
  • Analysis of PTP involvement in key signaling pathways relevant to cancer development.
  • Identification of specific PTPs implicated in gliomagenesis.

Main Results:

  • The study identifies several PTPs, including receptor-type (e.g., RPTPdelta, DEP1), intracellular (e.g., PTP1B, SHP2), dual-specific (e.g., MKP-1, PTEN), and CDC25 family members, as potentially involved in glioma biology.
  • These PTPs regulate critical signaling pathways implicated in cell growth, proliferation, and survival.
  • Dysregulation of PTP activity is increasingly recognized as a significant factor in glioma development.

Conclusions:

  • PTPs play a significant role in the molecular mechanisms underlying glioma development.
  • Targeting specific PTPs could offer novel diagnostic and therapeutic strategies for high-grade gliomas.
  • Further research into PTP function in gliomas is warranted to develop effective treatments.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: